Kyle Carver
Chief Financial Officer · Evommune, Inc.
- 2025
- Jul 10, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kyle Carver files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 7. Cooperative Ua Lsp - $25.00M in EVMN purchases and sales in the last 12 months
- Weegen Felice Isabel Verduyn-Van - $25.00M in EVMN purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $20.00M in EVMN purchases and sales in the last 12 months
- Luis C. Pena - $551K in EVMN purchases and sales in the last 12 months
- Janice Suzann Drew - $453K in EVMN purchases and sales in the last 12 months
- Jeegar Pravinkumar Patel - $413K in EVMN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kyle Carver?
Kyle Carver is a corporate insider, tracked as Chief Financial Officer of Evommune, Inc. (EVMN). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kyle Carver last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 5 filings going back to 2025.
Has Kyle Carver been buying or selling stock?
Recorded transactions: 1 open-market purchase ($13K) and 1 open-market sale ($415K) across all tracked filings.
